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In Brief
Restriction factors defend infected cells
against viruses. Maelfait et al. find that
SAMHD1, which blocks HIV-1 infection in
myeloid cells, prevents innate sensing of
infection via cGAS/STING. Furthermore,
SAMHD1 curtails virus-specific T cell
responses in vivo. Restriction by
SAMHD1, therefore, limits subsequent
innate and adaptive immune responses.
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SAMHD1 is a restriction factor for HIV-1 infection.
SAMHD1 mutations cause the autoinflammatory Ai-
cardi-Goutie`res syndrome that is characterized by
chronic type I interferon (IFN) secretion. We show
that the spontaneous IFN response in SAMHD1-defi-
cient cells and mice requires the cGAS/STING cyto-
solic DNA-sensing pathway. We provide genetic
evidence that cell-autonomous control of lentivirus
infection in myeloid cells by SAMHD1 limits virus-
induced production of IFNs and the induction of co-
stimulatory markers. This program of myeloid cell
activation required reverse transcription, cGAS and
STING, and signaling through the IFN receptor.
Furthermore, SAMHD1 reduced the induction of
virus-specific cytotoxic T cells in vivo. Therefore,
virus restriction by SAMHD1 limits the magnitude of
IFN and T cell responses. This demonstrates a
competition between cell-autonomous virus control
and subsequent innate and adaptive immune re-
sponses, a concept with important implications for
the treatment of infection.
INTRODUCTION
Virus infection in mammalian hosts is controlled by a variety of
mechanisms operating at different levels. These include cell-
intrinsic restriction systems, innate immune sensors that signal
for the induction of an antiviral state, and cellular and adaptive
immune responses. How these different branches of the antiviral
response work together is important for successful immunity.
The role of pattern-recognition receptors that sense infection
for the development of subsequent immune responses has
been well documented (Medzhitov, 2009). However, less is
known about how virus control by restriction factors is linked
with innate and adaptive immune responses.
Restriction factors have been studied in particular detail for
HIV-1 and include APOBEC3G, TRIM5a, tetherin, and Mx2
(Rehwinkel, 2014; Simon et al., 2015). Another HIV-1 restriction
factor is SAMHD1, a deoxynucleoside triphosphate (dNTP) tri-1492 Cell Reports 16, 1492–1501, August 9, 2016 ª 2016 The Author
This is an open access article under the CC BY license (http://creativephosphohydrolase that depletes the intracellular pool of dNTPs
and thereby prevents HIV-1 reverse transcription in some cell
types (Ayinde et al., 2012). Additional mechanisms by which
SAMHD1 might restrict infection have been proposed and
include degradation and/or binding of viral nucleic acids (Ballana
and Este´, 2015).
Several studies suggested that SAMHD1-deficient cells pro-
duce elevated levels of type I interferons (IFNs) in response to
HIV-1 infection. Indirect evidence for this idea stems from exper-
iments using Vpx, a viral accessory protein encoded by HIV-2,
but not HIV-1. Vpx targets SAMHD1 for proteasomal degrada-
tion (Hrecka et al., 2011; Laguette et al., 2011). Depletion of
SAMHD1 by Vpx in cultured human cells not only facilitates
HIV-1 infection but also results in the induction of an antiviral
response (Manel et al., 2010). In addition, cells from patients
with SAMHD1 mutations or cells in which SAMHD1 is depleted
by RNAi produce more IFNs during HIV-1 infection (Berger
et al., 2011; Puigdome`nech et al., 2013). Subsequent work iden-
tified a role for cytosolic DNA sensing by cGAS and STING in IFN
induction in Vpx-treated cells (Gao et al., 2013; Lahaye et al.,
2013). Furthermore, SAMHD1 depletion in vitro in human den-
dritic cells (DCs) by Vpx delivery or RNAi enhances DC activation
and antigen presentation upon HIV-1 infection and facilitates
T cell responses in co-culture models (Ayinde et al., 2015). How-
ever, the interpretation of these data is complicated by the pos-
sibility that Vpx targets additional proteins apart from SAMHD1
(Fujita et al., 2012; Reinhard et al., 2014), by genetic heterogene-
ity of patients’ cells, and by recent results that failed to reproduce
enhanced DC activation in HIV-1-infected cells depleted of
SAMHD1 (Hertoghs et al., 2015). In vivo data and genetic studies
in knockout models interrogating the possible role of SAMHD1 in
innate and adaptive immune responses to HIV-1 are currently
lacking.
Mutations in human SAMHD1 cause Aicardi-Goutie`res syn-
drome (AGS), a rare monogenic disorder resembling congenital
virus infection and typified by early-onset brain disease (Rice
et al., 2009). AGS patients spontaneously produce IFNs in the
absence of infection with exogenous viruses (Crow and Manel,
2015). These observations suggest that SAMHD1 prevents the
accumulation of endogenous nucleic acids that induce IFNs.
Others and we previously reported spontaneous IFN production
in Samhd1/mice and cells, mimicking the situation in AGS pa-
tients (Behrendt et al., 2013; Rehwinkel et al., 2013). The identity(s).
commons.org/licenses/by/4.0/).
Figure 1. Loss of SAMHD1 Triggers a Spontaneous cGAS/STING-Dependent IFN Response
(A and B) BMDMs of the indicated genotypes were cultured for 12 days.
(A) mRNA expression of the indicated ISGs byRT-qPCR. Data are presented as fold changes compared to the average of wild-type (C57Bl/6) samples. Each open
circle represents mean gene expression from two BMDM cultures from one mouse (n = 5).
(B) Western blot for ISG15, SAMHD1, and b-ACTIN (ACTB) using protein lysates from BMDMs. High-molecular-weight signals represent ISGylated proteins.
(C)mRNA expression of the indicated ISGs by RT-qPCR. Data are presented as fold changes compared to themean of wild-type samples. Open circles represent
gene expression values from individual 6-month-old mice. At least three mice were analyzed per genotype.
Data in (A) and (B) are representative of two independent experiments. Data in (A) and (C) represent mean ± SD (*p < 0.05, Student’s t test).and source of the cellular IFN-stimulatory nucleic acid and the
signaling pathway activated by it are important open questions
(Roers et al., 2016).
Weshow that cGASandSTINGmediatechronic IFNproduction
inSamhd1/miceandcells.We further show thatSAMHD1-defi-
cientmyeloid cells produce heightened levels of IFNs in response
to infection with VSV-G-pseudotyped HIV-1-derived lentiviruses
and are activated more strongly. These effects required reverse
transcription and were nullified in cells from Samhd1/ mice
also lacking cGAS, STING, or IFNAR. We also demonstrate that
the induction of antigen-specific T cell responses is limited by
SAMHD1 in vivo. Therefore, virus control by SAMHD1 at the level
of the infected cell limits innate and adaptive immunity.
RESULTS
The Spontaneous IFN Response in Samhd1/ Cells and
Mice Requires cGAS and STING
AGS is a prototypical interferonopathy, a group of diseases char-
acterized by chronic and pathologic IFN production (Crow and
Manel, 2015). Mutation of SAMHD1 or one of at least six other
genes, including TREX1 and RNASEH2A-C, causes AGS (Crowand Manel, 2015). Others and we previously showed that
Samhd1/mice and cells display a spontaneous IFN signature,
although SAMHD1-deficient animals do not develop autoimmu-
nity (Behrendt et al., 2013; Rehwinkel et al., 2013). Given that
SAMHD1’s enzymatic function is to degrade dNTPs, the building
blocks of DNA, we hypothesized that cytosolic DNA sensing
might account for IFN induction in the absence of SAMHD1.
To test this, we first cultured bone marrow-derived macro-
phages (BMDMs) from SAMHD1-cGAS (Mb21d1/) or
SAMHD1-STING (Tmem173/) double-knockout mice. Consis-
tent with previous observations, Samhd1/ BMDMs expressed
higher mRNA levels of the interferon-stimulated genes (ISGs)
Ifi44, Ifit1, and Ifit2 compared to wild-type cells (Figure 1A). How-
ever, the expression of these ISGs was not increased in cells
lacking both SAMHD1 and STING or cGAS compared to sin-
gle-knockout control cells (Figure 1A). It is noteworthy that basal
ISG expression was reduced in cGAS- and STING-deficient
cells. Wild-type BMDMs thus maintain basal expression of
ISGs and this requires an intact cytosolic DNA-sensing pathway.
ISG15 is an IFN-inducible ubiquitin-like protein modifier with
antiviral functions (Morales and Lenschow, 2013). Samhd1/
cells expressed more ISG15 protein and contained increasedCell Reports 16, 1492–1501, August 9, 2016 1493
amounts of high-molecular-weight proteins, which were cova-
lently modified by ISG15 (Figure 1B). Enhanced ISGylation was
not observed in SAMHD1-deficient BMDMs that did not express
cGAS or STING (Figure 1B).
To confirm these findings in vivo, we analyzed spleens from
6-month-old Samhd1/ mice for the expression of several
ISGs. ThemRNA levels of Ifi44, Ifit1,Oasl1, and Isg15were signif-
icantly increased in Samhd1/ spleens (Figure 1C). However,
the expression of these genes was reduced to wild-type levels
when SAMHD1 was knocked out together with cGAS or STING
(Figure 1C). In sum, these data show that SAMHD1 prevents
spontaneous engagement of the cGAS/STING pathway.
SAMHD1 Limits IFN Induction and Myeloid Cell
Activation upon Lentivirus Infection
Vpx-mediated degradation of SAMHD1 enables productive
infection of human DCs and relieves a block to IFN induction
and DC activation (Figure S1) (Manel et al., 2010). To test this
in a genetically tractable system, we generated bone marrow-
derived myeloid cells (BMMCs) from wild-type and Samhd1/
mice (Helft et al., 2015). Others and we previously showed that
SAMHD1 restricts infection of these cells with HIV-1-based len-
tiviruses (Behrendt et al., 2013; Rehwinkel et al., 2013). Profound
SAMHD1-dependent restriction both in vitro and in vivo was only
observed when the pol gene carried a point mutation (V148I),
which decreases the affinity of the viral RT for dNTPs (Rehwinkel
et al., 2013). Second-generation lentiviruses used in our previous
study (SGLenti-RTV148I), which have aminimal genome encoding
only EGFP (Figure S2A), were efficiently restricted by SAMHD1,
but they did not induce BMMC activation or IFN secretion (Fig-
ures S2C–S2E) (Rehwinkel et al., 2013).
We therefore infected murine BMMCs with first-generation
lentiviruses (FGlenti) that induce IFN in humanmonocyte-derived
dendritic cells (MDDCs) (Figure S1). To allow for potent restric-
tion by SAMHD1, we introduced the V148I point mutation into
the pol gene of FGLenti (Figure S2A). Infection of BMMCs with
both first- and second-generation lentiviruses was equally sup-
pressed by SAMHD1 (Figures 2A and S2C). However, only
FGLenti-RTV148I induced cell surface expression of the co-stim-
ulatory molecules CD40, CD80, and CD86 and secretion of IFNa
and the chemokine CXCL10, and these effects were significantly
elevated in SAMHD1-deficient cells (Figures 2B, 2C, S2D, and
S2E). Ifit1 and Ifi44 mRNA and ISG15 protein expression and
conjugation were enhanced in SAMHD1-deficient BMMCs (Fig-
ures 2D and 2E). Taken together, these data provide direct ge-
netic evidence that SAMHD1-mediated restriction impedes
detection of lentivirus infection in myeloid cells.
Viral cDNA Synthesis Is Required for Myeloid Cell
Activation
To determine at which step in the viral life cycle HIV-1 is sensed
in SAMHD1-deficient myeloid cells, we treated BMMCs with the
RT inhibitor nevirapine or the integrase inhibitor raltegravir during
infection with FGLenti-RTV148I. Both compounds inhibited infec-
tion (Figure 3A), but only inhibition of reverse transcription
prevented BMMC activation and CXCL10 and IFNa production
(Figures 3B, 3C, S3A, and S3B). SAMHD1 may restrict HIV by
multiple mechanisms, including by preventing cDNA synthesis1494 Cell Reports 16, 1492–1501, August 9, 2016and by degrading incoming viral genomic RNA. We found that
HIV-1 cDNA accumulated over 24 hr at 10-fold higher levels in
Samhd1/ BMMCs compared to wild-type cells (Figure 3D).
In contrast, viral RNA levels measured at 4 hr post-infection
were not affected by SAMHD1 (Figure 3E). At this time point
we observed higher induction of Ifnb and Ifit1 mRNAs in
SAMHD1-deficient BMMCs (Figure 3F). These results indicate
that viral RNAs do not trigger the IFN response at this time point,
which instead depends on reverse transcription and correlates in
magnitude with reverse transcription products.
Lentivirus-Induced Myeloid Cell Activation and IFN
Induction Are Dependent on cGAS/STING and IFN
Signaling
Given the requirement for reverse transcription, we tested
whether the cytosolic DNA-sensing pathway detects lentivirus
infection in SAMHD1-deficient myeloid cells. SAMHD1-cGAS
and SAMHD1-STING double-knockout BMMCs were equally
or slightly better infected by FGLenti-RTV148I than Samhd1/
cells (Figure 4A). BMMC activation, the secretion of CXCL10
and IFNa, and ISG15 protein expression and conjugation were
all greatly reduced in Samhd1/ BMMCs lacking cGAS or
STING (Figures 4B–4D and S4A). Neither BMMC activation nor
IFNa production were affected by loss of SAMHD1, cGAS, or
STING upon infection with Sendai virus (SeV), which is sensed
via the RIG-I pathway (Kato et al., 2006) (Figures 4E, 4F, and
S4B). Next, we assessed the role of IFN signaling in activation
of SAMHD1-deficient myeloid cells by infecting SAMHD1-
type I IFN receptor (Ifnar1/) double-knockout BMMCs with
FGlenti-RTV148I. Despite the fact that loss of the type I IFN recep-
tor further increased susceptibility to FGlenti-RTV148I compared
to SAMHD1 single-knockout cells (Figure 4G), BMMC activation
and antiviral responses in these cells were impaired (Figures 4H–
4J, S4C, and S4D). In sum, these observations provide genetic
evidence that cGAS, STING, and signaling through the type I
IFN receptor are required for SAMHD1-dependent myeloid cell
activation upon lentivirus infection.
SAMHD1 Reduces the Antiviral CD8 T Cell Response
In Vivo
Given that SAMHD1 curtails the induction of IFN and the activa-
tion of myeloid cells in vitro, we tested whether SAMHD1 limits
adaptive immune responses. We fused the OVA257–264 peptide
SIINFEKL, a model antigen for CD8 T cells (Carbone and Bevan,
1989), to the C terminus of the matrix protein (Figure S5A). The
resulting FGLenti-RTV148I SIINFEKL virus behaved identically to
the parental virus in terms of virus production, gag processing,
infectivity, and BMMC activation (Figures S5B–S5F). Further-
more, SIINFEKL presentation by H-2Kb was enhanced in
Samhd1/ cells (Figure 5A).
Next we compared the antigen-specific CD8 T cell response in
wild-type and Samhd1/ animals. Compared to wild-typemice,
infection of Samhd1/ animals resulted in 4- and 10-fold
increased tetramer-positive CD8 T cell populations in blood
and spleens, respectively (Figures 5B, 5C, and S5G). Spleens
of Samhd1/ mice contained more CD8 T cells producing
IFNg upon SIINFEKL re-stimulation than those of wild-type con-
trols (Figures 5D and 5E), but not after phorbol 12-myristate
Figure 2. SAMHD1 Limits Infection of BMMCs with First-Generation Lentiviruses and Prevents Innate Sensing
(A–E) Wild-type (+/+) or Samhd1/ (/) BMMCs were infected for 48 hr with FGlenti-RTV148I using the indicated MOIs.
(A) Infection was assessed by flow cytometry. BMMC cultures were gated on CD11c+ MHC-II+ cells (see Figure S2B). The fraction of GFP+ cells was then
determined. Representative FACS plots (left) and percentage of GFP+ cells are shown (right) (n = 4).
(B) Activation of CD11c+ MHC-II+ BMMCs was analyzed by cell surface staining for CD40, CD80, and CD86. Upper panels depict representative histograms of
non-infected (dashed lines) and infected (solid lines, MOI = 0.3) cells. CD40, CD80, and CD86 median fluorescence intensity (MFI) of cells infected with different
MOIs is quantified in the bottom graphs (n = 4).
(C) CXCL10 in cell culture supernatant was measured by ELISA (n = 4).
(D) Ifit1 and Ifi44 mRNA expression was analyzed by RT-qPCR in bulk BMMC cultures (n = 4).
(E) ISG15, SAMHD1, and b-ACTIN (ACTB) were analyzed by western blot using protein lysates from bulk BMMC cultures (MOI = 0.3).
Data are representative of three (A–C) and two (D and E) independent experiments. Data in (A)–(D) represent mean ± SD (*p < 0.05 and ***p < 0.001, two-way
ANOVA). See also Figures S1 and S2.13-acetate (PMA) and ionomycin stimulation (Figure S5H).
SAMHD1-cGAS double-knockout mice mounted a similar anti-
gen-specific CD8 T cell response compared to mice lacking
only SAMHD1 (Figure S5I). This indicates that the increased
antigen load in Samhd1/ animals determines the magnitude
of the CD8 T cell response in this model. To exclude direct
effects of SAMHD1 on the CD8 T cell repertoire or T cell activa-
tion, we injected Samhd1/ and wild-type mice with OVA pro-
tein using cGAMP as an adjuvant (Li et al., 2013). This resulted
in comparable SIINFEKL-specific CD8 T cell responses in wild-
type and Samhd1/ mice (Figures S5J and S5K). We conclude
that SAMHD1 limits lentivirus-specific T cell responses to lentivi-
ral infection in vivo.DISCUSSION
Our study provides genetic and in vivo data that the restriction
factor SAMHD1 does not operate in conjunction with other
innate and adaptive immune responses to ensure control of lenti-
virus infection. Instead, SAMHD1 limits the induction of IFNs,
ISGs and co-stimulatorymolecules as well as the amounts of an-
tigen presented by infected myeloid cells in vitro. Furthermore,
SAMHD1 limits the magnitude of the CD8 T cell response
induced in vivo. Cell-autonomous virus restriction by SAMHD1,
therefore, competes with sensors of infection and T cell re-
sponses. This antagonistic relationship between SAMHD1 and
innate and adaptive immune responses is of importance forCell Reports 16, 1492–1501, August 9, 2016 1495
Figure 3. Sensing of First-Generation Lenti-
virus in Samhd1/ BMMCs Requires the
Accumulation of Reverse Transcription
Products
(A–F) Wild-type (+/+) or Samhd1/ (/) BMMCs
were infected with FGlenti-RTV148I (MOI = 0.3) in
the presence of nevirapine (NEV) or raltegravir
(RAL) (A–C).
(A) Infectivity was measured as in Figure 2A 48 hr
after infection (n = 4).
(B) Cell surface expression of CD86 was assessed
as in Figure 2B 48 hr after infection (n = 4).
(C) CXCL10 in cell culture supernatants was
measured by ELISA 48 hr after infection (n = 4).
(D) cDNA production was measured by qPCR.
Total DNA was extracted from BMMCs at different
hours post-infection (p.i.). The dashed line depicts
EGFP expression in wild-type BMMCs at 16 hr p.i.
in the presence of NEV as a control for plasmid
contamination of the virus preparation (n = 2).
(E) Viral genomic RNAwasmeasured by RT-qPCR
using total RNA extracted from BMMCs at 4 hr p.i.
(F) Ifnb and Ifit1 mRNA expression was analyzed
by RT-qPCR in bulk BMMC cultures at 4 hr p.i.
(n = 2).
Data are representative of three (A–C) or two (D–F)
independent experiments. Data in (A)–(F) repre-
sent mean ± SD (*p < 0.05 and **p < 0.01; one-way
ANOVA, A–C; two-way ANOVA, D and F; unpaired
t test, E). See also Figure S3.our understanding of lentiviral pathogenicity, and it may provide
therapeutic opportunities to control viral infections.
It is interesting to ask whether this concept also applies to
other restriction factors. Indeed, a recent study showed that
cultured DCs inactivate TRIM5a’s function by redirecting the
protein to the cell nucleus, and it suggested that this reflects
an evolutionary trade-off in DCs, in which restriction is minimized
to allow for more efficient sensing (Portilho et al., 2016). How-
ever, other restriction factors do not compete with but rather
facilitate subsequent innate and adaptive immune responses.
APOBEC3 is required for efficient production of antibodies in
retrovirus-infected mice (Santiago et al., 2008, 2010; Smith
et al., 2011), and human APOBEC3G facilitates T cell responses
(Casartelli et al., 2010). Tetherin promotes NK and CD8 T cell re-
sponses in a mouse model of retrovirus infection (Li et al., 2014).
Interestingly, some restriction factors, including TRIM5a and
tetherin, also operate as sensors of infection and induce NF-kB
(Gala˜o et al., 2012; Pertel et al., 2011). Viral restriction factors
thus differentially impact the host’s immune responses, and
it is likely that this complexity is due to host-pathogen co-
evolution.
A first hint at the possibility that SAMHD1 prevents sensing
of virus infection came from its implication in AGS, a rare
autoinflammatory disease characterized by chronic IFN pro-
duction (Rice et al., 2009). Here we show that the sponta-
neous IFN response in Samhd1/ cells and mice requires
cGAS and STING. Together with our previous observation
that Samhd1/ cells respond normally to stimulation with
exogenous DNA or STING agonists (Rehwinkel et al., 2013),
these data suggest that an unusual endogenous DNA accumu-
lates in SAMHD1-deficient cells and engages cGAS. This mir-1496 Cell Reports 16, 1492–1501, August 9, 2016rors the situation in TREX1- and RNASEH2-deficient cells
(Roers et al., 2016).
We further report that IFN production in lentivirus-infected
Samhd1/ myeloid cells requires cGAS and STING. Induction
of antiviral responses was dependent upon reverse transcrip-
tion, implicating viral reverse-transcribed DNA as the cGAS
trigger. These data provide genetic evidence that lentivirus-
induced innate immune responses are dependent on cytosolic
DNA sensing. As reported for human DCs (Manel et al., 2010),
we find that first-generation lentiviruses encoding a full genome
and second-generation viruses with a minimal genome differ in
their abilities to induce IFN. It has been suggested that newly ex-
pressed gag unmasks non-integrated cDNA in the DC cytosol,
making it available for detection by cGAS (Lahaye et al., 2013;
Manel et al., 2010). Indeed, gag is expressed by first-generation
lentiviruses, but not by second-generation viruses. Specific
nucleic acid sequences or secondary structures only present in
the full HIV-1 genome may also, perhaps in conjunction with
additional host proteins, contribute to IFN induction (Herzner
et al., 2015; Yoh et al., 2015).
To study the impact of lentivirus restriction by SAMHD1 on
cytotoxic T cell responses in an in vivo model, we generated a
lentivirus expressing the OVA peptide SIINFEKL. We found that
infected Samhd1/ myeloid cells better presented this model
antigen. Enhanced antigen presentation also had been observed
in HIV-1-infected human DCs upon SAMHD1 depletion with Vpx
or RNAi, and these treatments resulted in stronger T cell re-
sponses in co-culture models (Ayinde et al., 2015; Manel et al.,
2010). These in vitro studies, however, mostly relied on HIV-1-
specific memory T cells, which have altered requirements for
activation (Berard and Tough, 2002). It was, therefore, important
Figure 4. BMMC Activation by First-Generation Lentivirus Is Dependent on cGAS, STING, and IFN Signaling
(A–J) BMMCs of the indicated genotypes were infected for 48 hr with FGLenti-RTV148I or SeV.Wedges in (A)–(C), (E), and (F) represent increasingMOIs of FGLenti-
RTV148I (0.1, 0.3, and 1) or SeV (0.02, 0.1, and 0.5). Tmem173, Mb21d1, and Ifnar1 are the genes encoding STING, cGAS, and type I IFN receptor.
(A) Infectivity was measured as in Figure 2A (n = 4).
(B) Cell surface expression of CD86 was assessed as in Figure 2B (n = 4).
(C) CXCL10 and IFNa in cell culture supernatants were measured by ELISA (n = 4).
(D) ISG15, SAMHD1, and b-ACTIN (ACTB) were analyzed by western blot (MOI = 0.3).
(E) Cell surface expression of CD86 was assessed as in Figure 2B (n = 2).
(F) IFNa in cell culture supernatants was measured by ELISA (n = 2).
(G) Infectivity was measured as in Figure 2A (n = 2).
(H) Cell surface expression of CD86 was assessed as in Figure 2B (n = 2).
(I) CXCL10 in cell culture supernatants was measured by ELISA (n = 2).
(J) ISG15, SAMHD1, and b-ACTIN (ACTB) were analyzed by western blot.
Data are representative of three independent experiments. Data in (A)–(C) and (E)–(I) represent mean ± SD (**p < 0.01, ***p < 0.001, and ****p < 0.0001; two-way
ANOVA, A–C, E, F, H, and I; one-way ANOVA, G). See also Figure S4.
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Figure 5. SAMHD1 Prevents Lentivirus-Specific CD8 T Cell Responses In Vivo
(A) GFP expression (infectivity) and antigen presentation (using a H2-Kb SIINFEKL-specific antibody) were analyzed by flow cytometry in CD11c+ MHC-II+
BMMCs 48 hr after infection with FGlenti-RTV148I or FGLenti-RTV148I SIINFEKL (MOI = 0.3). Representative FACS plots are shown on the left and a quantification of
infected cells presenting SIINFEKL on MHC-I (GFP+ H2-Kb SIINFEKL+) is shown in the right panel (n = 4).
(B–E) Wild-type (C57Bl/6, n = 6) and Samhd1/ mice (n = 5) were intravenously infected with FGLenti-RTV148I SIINFEKL (100,000 IU/mouse).
(B and C) Quantification of H2-Kb-SIINFEKL tetramer+ CD8 T cells in the blood 9 days p.i. (B) and in the spleen 10 days p.i. (C). Each dot represents an individual
mouse. Representative FACS plots are shown on the right. Numbers indicate percentages of tetramer+ CD8 T cells.
(D) Intracellular IFNg staining of spleen cells from (C) after 6 hr of SIINFEKL peptide (1013–108 M) re-stimulation. Percentages of IFNg+ CD8 T cells are shown.
The dashed line represents the fraction of IFNg+ CD8 T cells responding to peptide in an uninfected mouse.
(E) Representative FACS plots after re-stimulation with 1010 M SIINFEKL. Numbers indicate percentages of IFNg+ CD8 T cells.
Data are representative of two independent experiments. Data in (A)–(D) represent mean ± SD (*p < 0.05 and ****p < 0.0001; unpaired t test, A–C; non-linear 4PL
sigmoidal curve fitting, D). See also Figure S5.
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to establish an in vivo model in which naive T cells are primed.
Notably, we found that antigen-specific CD8 T cell responses
were up to 10-fold stronger in Samhd1/ mice compared to
wild-type controls upon infection with the SIINFEKL-encoding
lentivirus. It is interesting to ask whether this is due to enhanced
antigen levels and/or to augmented co-stimulation and secretion
of cytokines by antigen-presenting cells. We found that the
SIINFEKL-specific T cell response was similarly enhanced in in-
fected Samhd1/ and Samhd1/; Mb21d1/ animals. Thus,
in this setting, increased antigen levels are largely responsible
for the effect of SAMHD1 on the T cell response. However,
H-2Kb-bound SIINFEKL elicits strong T cell responses due to
its exceptionally high affinity for the T cell receptor, and little sig-
nals 2 and 3 (co-stimulation and cytokines) are required for the
SIINFEKL response (Denton et al., 2011). It will therefore be inter-
esting to test other antigens in the future.
An interesting comparison can be made with HIV-2, which
overcomes SAMHD1-mediated restriction by encoding the
antagonist Vpx (Hrecka et al., 2011; Laguette et al., 2011). In
line with our conclusion that SAMHD1 limits immune responses,
in vitro infection of DCs with HIV-2 results in potent IFN induction
(Lahaye et al., 2013). In humans, HIV-2 infection in comparison
with HIV-1 infection is characterized by better immune control,
and fewer HIV-2-infected individuals progress to disease
(Nyamweya et al., 2013; Rowland-Jones and Whittle, 2007). It
is possible that these effects are due in part to relief of
SAMHD1-mediated restriction in HIV-2-infected cells, allowing
for better innate and adaptive immune responses, and
that HIV-1 has become the more successful pathogen by
allowing itself to be restricted by SAMHD1. Consistent with
this notion are observations in HIV-1 elite controllers. The
expression level of SAMHD1 is reduced in DCs from elite control-
lers; these cells mount enhanced IFN responses to infection and
are superior in vitro in stimulating CD8 T cells (Martin-Gayo et al.,
2015).
These observations, together with the genetic evidence pre-
sented here for an inhibitory role of SAMHD1 on immune re-
sponses, suggest a strategy for the development of an efficient
HIV-1 vaccine in the form of a replication-deficient virus that
circumvents restriction by SAMHD1. These could be achieved
either by inclusion of Vpx or by the development of small mole-
cule inhibitors of SAMHD1. Pharmacological inhibition of
SAMHD1 also could be useful in therapeutic approaches aimed
at eradicating latent HIV-1. These strategies often rely on
re-activation of latent provirus and subsequent killing of the
virus by the immune system, which we predict would be
more effective in the absence of SAMHD1 (Margolis and
Hazuda, 2013). In sum, our work sheds light on the in vivo inter-
play among different branches of the antiviral immune system,
and these insights have important implications for controlling
infection.EXPERIMENTAL PROCEDURES
Mice
All mice were on the C57Bl/6 background. Samhd1/ mice were described
previously (Rehwinkel et al., 2013). Ifnar1/ mice were a gift from C. Reis e
Sousa and were originally described in (M€uller et al., 1994). Tmem173/(STING-deficient) mice were a gift from J. Cambier (Jin et al., 2011).
Mb21d1/ (cGAS knockout first) mice were described in Bridgeman et al.
(2015). This work was performed in accordancewith the UK Animals (Scientific
Procedures) Act 1986 and institutional guidelines for animal care. This work
was approved by a project license granted by the UK Home Office (PPL No.
40/3583) and also was approved by the Institutional Animal Ethics Committee
Review Board at the University of Oxford.
Virus Production, Infection, and OVA-cGAMP Immunizations
All lentiviruses were produced in TLA HEK293T cells. Cells were transfected
using Fugene6 (Promega) using the plasmid combinations listed in Table S2.
All viruses were VSV-G pseudotyped. Medium was replaced the day after
transfection, and 48 hr later supernatant was collected and filtered through a
0.45-mm polyethersulfone (PES) filter. Virus was concentrated by centrifuga-
tion over a 20% sucrose cushion at 50,0003 g for 2 hr. Viral titers were deter-
mined on TLA HEK293T cells by fluorescence-activated cell sorting (FACS)
based on GFP expression. Target cells were infected in the presence of
8 mg/ml polybrene (Sigma-Aldrich). After 2 hr, the inoculum was washed
away and replaced with fresh medium. For measuring viral cDNA and RNA,
virus was incubated with 10 U/ml DNase I (Turbo DNase I, Thermo Fisher Sci-
entific) for 30 min at 37C in 13 reaction buffer diluted in RPMI. Then 10 mM
nevirapine or raltegravir was added to the cells 30 min prior to infection.
Mice were infected by intravenous injection of 100,000 IU of FGLenti-RTV148I
SIINFEKL (see Figure S5G for virus titration). For immunization with OVA and
cGAMP, mice were anesthetized with isoflurane and injected intramuscularly
with 10 mg 2030-cGAMP (Biolog, C 161) and 10 mg endotoxin-free OVA (Hyglos,
321000).
In Vitro Peptide Restimulation Assay
Spleen cells (2 3 106) were stimulated with SIINFEKL peptide (InvivoGen,
1013–108 M). After 1 hr, 10 mg/ml brefeldin A (Sigma-Aldrich) was added
to the cells, and 5 hr later, cells were collected for intracellular IFNg staining.
Cells were stained for cell surface markers and intracellular molecules, and
they were fixed and permeabilized in Cytofix/Cytoperm (BD Biosciences) ac-
cording to the manufacturer’s instructions.
Statistics
Statistical analysis was performed in GraphPad Prism v7.00 as detailed in the
figure legends.
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